10-54132840-TACACACACACAC-TACACACACAC

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_033056.4(PCDH15):​c.1917+33_1917+34delGT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0361 in 1,371,676 control chromosomes in the GnomAD database, including 795 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.045 ( 233 hom., cov: 0)
Exomes 𝑓: 0.035 ( 562 hom. )

Consequence

PCDH15
NM_033056.4 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0900

Publications

2 publications found
Variant links:
Genes affected
PCDH15 (HGNC:14674): (protocadherin related 15) This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008]
PCDH15 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 23
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1F
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 10-54132840-TAC-T is Benign according to our data. Variant chr10-54132840-TAC-T is described in ClinVar as Benign. ClinVar VariationId is 227006.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0871 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH15NM_033056.4 linkc.1917+33_1917+34delGT intron_variant Intron 15 of 32 ENST00000320301.11 NP_149045.3 Q96QU1-1
PCDH15NM_001384140.1 linkc.1917+33_1917+34delGT intron_variant Intron 15 of 37 ENST00000644397.2 NP_001371069.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH15ENST00000320301.11 linkc.1917+33_1917+34delGT intron_variant Intron 15 of 32 1 NM_033056.4 ENSP00000322604.6 Q96QU1-1
PCDH15ENST00000644397.2 linkc.1917+33_1917+34delGT intron_variant Intron 15 of 37 NM_001384140.1 ENSP00000495195.1 A0A2R8Y6C0

Frequencies

GnomAD3 genomes
AF:
0.0450
AC:
6758
AN:
150298
Hom.:
233
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0896
Gnomad AMI
AF:
0.00554
Gnomad AMR
AF:
0.0311
Gnomad ASJ
AF:
0.0348
Gnomad EAS
AF:
0.00157
Gnomad SAS
AF:
0.0483
Gnomad FIN
AF:
0.0276
Gnomad MID
AF:
0.0865
Gnomad NFE
AF:
0.0274
Gnomad OTH
AF:
0.0538
GnomAD2 exomes
AF:
0.0497
AC:
6969
AN:
140090
AF XY:
0.0508
show subpopulations
Gnomad AFR exome
AF:
0.124
Gnomad AMR exome
AF:
0.0292
Gnomad ASJ exome
AF:
0.0536
Gnomad EAS exome
AF:
0.00372
Gnomad FIN exome
AF:
0.0424
Gnomad NFE exome
AF:
0.0475
Gnomad OTH exome
AF:
0.0543
GnomAD4 exome
AF:
0.0351
AC:
42815
AN:
1221270
Hom.:
562
AF XY:
0.0359
AC XY:
21703
AN XY:
604248
show subpopulations
African (AFR)
AF:
0.109
AC:
3037
AN:
27934
American (AMR)
AF:
0.0267
AC:
892
AN:
33430
Ashkenazi Jewish (ASJ)
AF:
0.0467
AC:
973
AN:
20822
East Asian (EAS)
AF:
0.00134
AC:
46
AN:
34262
South Asian (SAS)
AF:
0.0587
AC:
4136
AN:
70456
European-Finnish (FIN)
AF:
0.0338
AC:
1469
AN:
43424
Middle Eastern (MID)
AF:
0.0825
AC:
417
AN:
5054
European-Non Finnish (NFE)
AF:
0.0318
AC:
29774
AN:
935136
Other (OTH)
AF:
0.0408
AC:
2071
AN:
50752
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.424
Heterozygous variant carriers
0
1862
3724
5585
7447
9309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1094
2188
3282
4376
5470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0450
AC:
6764
AN:
150406
Hom.:
233
Cov.:
0
AF XY:
0.0446
AC XY:
3276
AN XY:
73418
show subpopulations
African (AFR)
AF:
0.0895
AC:
3666
AN:
40960
American (AMR)
AF:
0.0311
AC:
469
AN:
15102
Ashkenazi Jewish (ASJ)
AF:
0.0348
AC:
120
AN:
3444
East Asian (EAS)
AF:
0.00157
AC:
8
AN:
5082
South Asian (SAS)
AF:
0.0485
AC:
231
AN:
4760
European-Finnish (FIN)
AF:
0.0276
AC:
284
AN:
10308
Middle Eastern (MID)
AF:
0.0822
AC:
24
AN:
292
European-Non Finnish (NFE)
AF:
0.0274
AC:
1846
AN:
67470
Other (OTH)
AF:
0.0532
AC:
111
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
295
591
886
1182
1477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0649
Hom.:
79

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 08, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.1917+13GT[10] in intron 15 of PCDH15: This variant is not expected to have cli nical significance because it is not located within the splice consensus sequenc e. It has been detected in 8.9% (4209/47276) of chromosomes across several diver se populations by the Exome Aggregate Consortium (http://exac.broadinstitute.org /variant/10-55892600-TAC-T). -

Autosomal recessive nonsyndromic hearing loss 23 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 1F Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Aug 08, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.090
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5785040; hg19: chr10-55892600; API